Project description
It may be the quality and not the quantity that counts when it comes to proteins
Proteins are ubiquitous, mediating structural and functional roles in all cells. Their dysfunction is intimately involved in disease and one important way to assess their activity is to screen for their expression (proteomics assays looking at the entire complement of proteins expressed by an organism). However, many disease processes may alter protein function – intricately related to structure – without altering expression. The EU-funded project Proteomes-in-3D is testing a novel methodology to measure altered structures within the entire proteome of an organism and determine whether they are correlated with complex phenotypes. The team is focusing on protein aggregates or superassemblies (SAs), given that SAs are involved in both normal and disease processes. In addition, they will create an atlas of structural proteome dynamics from data generated throughout the project to provide a firm foundation for future studies of the structural proteome.
Objective
Protein expression screens are routinely used to identify biological processes deregulated upon disease development or upon specific cellular perturbations. Generating molecular hypotheses from these omic data remains challenging, however, and many molecular events that modulate protein function do not involve altered protein levels. With this project, I propose a new paradigm. I propose that by measuring altered structures of proteins on a global scale, we can capture altered functional states of proteins and proteomes. I propose that the new approach will support the generation of testable molecular hypotheses from global data and the development of new frameworks for the modelling of biological systems.
Building on a unique mass spectrometric approach my lab developed, which captures protein structural changes on a proteome-wide scale, we will assess the performance of the global structural readout at analyzing complex phenotypes. We will apply it to a biomedical problem of interest to my lab: the functional and pathological implications of protein aggregates or superassemblies (SAs).
Protein aggregates form not only during disease but also under physiological conditions. These structures regulate important normal processes and contribute to cellular architecture. Using the new structural approach, we will identify and characterize networks of novel functional SAs in E. coli, mouse, and human proteomes. We will assess how genomic variation, environment and age modulate protein structures and SA assembly and how SAs are linked to phenotypes. Last, we will translate our approach to a clinical setting and ask whether altered protein structures can serve as biomarkers of disease, specifically Parkinsons disease and how SAs underlie Parkinsons subtypes. We will collect the wealth of dynamic structural data generated through this project into an Atlas of Structural Proteome Dynamics and use the data to shed new light on features of the structural proteome.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences biochemistry biomolecules proteins proteomics
- medical and health sciences basic medicine neurology parkinson
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.1.1. - EXCELLENT SCIENCE - European Research Council (ERC)
MAIN PROGRAMME
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
ERC-COG - Consolidator Grant
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) ERC-2019-COG
See all projects funded under this callHost institution
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
8092 Zuerich
Switzerland
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.